International Journal of Multiple Sclerosis and Related Disorders
Join a distinguished global community of neurologists, neuroimmunologists, multiple sclerosis specialists, demyelinating disease researchers, neuroscientists, clinical investigators, rehabilitation medicine experts, physical therapists, occupational therapists, and translational scientists dedicated to advancing understanding of multiple sclerosis pathophysiology, autoimmune demyelination mechanisms, neurodegeneration, neuroimmune interactions, disease-modifying therapies, and therapeutic innovations through cutting-edge research, clinical trial findings, and collaborative scientific investigations for improved patient outcomes worldwide.
Why Join Our Research Network?
The International Journal of Multiple Sclerosis and Related Disorders offers exclusive membership benefits to neurologists, neuroimmunologists, MS specialists, clinical researchers, rehabilitation medicine experts, scientists, physical therapists, occupational therapists, and translational investigators advancing multiple sclerosis research, treatment outcomes, and quality of life improvements worldwide.
Reduced Publication Fees
Members receive up to 45% discount on article processing charges for all accepted manuscripts, making MS research accessible to academic medical centers, neurology departments, research hospitals, clinical practices, university neuroscience departments, pharmaceutical companies, biotechnology organizations, and independent investigators conducting demyelinating disease studies, autoimmune neuroinflammation research, and multiple sclerosis therapeutic development, disease-modifying treatment studies, and rehabilitation research worldwide.
Unlimited Submissions
Submit unlimited research manuscripts annually with comprehensive double-blind peer review from leading MS specialists, neuroimmunologists, clinical neurologists, and demyelinating disease experts ensuring rigorous scientific evaluation, constructive feedback, methodological guidance, and adherence to the highest publication standards in multiple sclerosis research, clinical neurology, and translational neuroimmunology investigations, and patient outcomes research.
Global Visibility
Your MS research reaches neurology departments, academic teaching hospitals, pharmaceutical companies, biotechnology firms, rehabilitation centers, clinical research organizations, and research institutions worldwide through extensive global indexing networks, search engine optimization, social media promotion, and open access distribution platforms ensuring maximum visibility.
Recognition
Receive official membership certificate and digital credentials recognizing your commitment to MS research for grant applications, academic promotions, tenure reviews, fellowship applications, research funding proposals, and professional portfolios throughout your academic career.
Priority Review
Members receive expedited manuscript processing with priority scheduling from our distinguished editorial board of MS experts, neuroimmunology specialists, clinical trial investigators, and rehabilitation medicine researchers with extensive expertise in demyelinating diseases and autoimmune neurology.
Select Your Membership Level
Flexible membership options designed for MS specialists, clinical neurologists, neuroimmunologists, rehabilitation physicians, physical medicine experts, graduate students, doctoral candidates, postdoctoral fellows, academic institutions, medical universities, pharmaceutical companies, biotechnology organizations, clinical research institutes, and research organizations advancing multiple sclerosis understanding, therapeutic development, disease-modifying treatment research, and clinical outcomes improvement worldwide.
Graduate students, doctoral candidates and postdoctoral researchers in neurology
- 30% APC Discount
- Unlimited Submissions
- Peer Review Access
- 1 User Account
Clinical researchers, neurologists, and neuroimmunology specialists
- 45% APC Discount
- Unlimited Submissions
- Priority Peer Review
- 1 User Account
Universities, academic medical centers and research institutes
- 45% APC Discount
- Unlimited Submissions
- Priority Peer Review
- 1-21+ User Accounts
Pharmaceutical companies, biotechnology organizations and clinical research firms
- 45% APC Discount
- Special Issue Access
- Priority Peer Review
- 10-15 User Accounts
How to Become a Member
Begin your membership journey with these three straightforward steps and start publishing your multiple sclerosis research discoveries, neuroimmunology innovations, clinical trial findings, and therapeutic advances to our extensive global network of neurologists and MS specialists.
Choose Your Tier
Select the membership level that aligns with your MS research needs, clinical specialty, career stage, institutional budget, publication volume goals, and collaborative research requirements.
Submit Application
Email [email protected] with your full name, academic credentials, institutional affiliation, MS or neurology research focus, publications list, and preferred membership tier.
Start Publishing
Receive your official membership certificate, digital credentials, professional recognition, and member portal access, then begin submitting manuscripts for expedited peer review, priority publication consideration, and accelerated editorial decisions.
Frequently Asked Questions
Find answers to common questions about exclusive membership benefits, manuscript publication process, peer review timelines, editorial guidelines, submission requirements, and support services for MS researchers and neuroimmunologists.
What research areas are covered?
The Journal welcomes original research on multiple sclerosis pathophysiology, autoimmune demyelination mechanisms, neuroimmunology, Phase I-IV clinical trials, disease-modifying therapies, rehabilitation medicine approaches, progressive MS, relapsing-remitting MS, pediatric MS, neuromyelitis optica spectrum disorders, and related demyelinating conditions affecting the central nervous system.
Can I upgrade my membership tier?
Yes, members can upgrade at any time during their active subscription period. Contact our dedicated membership services team for seamless tier transitions with prorated fees, updated benefits package, enhanced publication support services, and continuous editorial assistance.
What is the peer review timeline?
Our rigorous double-blind peer review typically completes within 4-6 weeks. Members receive priority processing and expedited editorial decisions from our expert review board of multiple sclerosis specialists, neuroimmunologists, and clinical neurology researchers.
Are clinical trial papers accepted?
Absolutely. We actively encourage submissions of Phase I-IV clinical trial results, real-world effectiveness studies, comparative treatment analyses, patient-reported outcomes, and long-term safety monitoring data for MS therapeutics and disease-modifying treatments.
How does open access benefit researchers?
Open access ensures your MS research reaches neurology departments, academic teaching hospitals, pharmaceutical companies, biotechnology organizations, rehabilitation centers, and research institutions worldwide without subscription barriers, maximizing research impact, citation potential, and collaborative opportunities.
What support services are available?
Members receive professional language editing, manuscript formatting assistance, figure preparation, statistical consultation, graphical abstract design, supplementary materials formatting, and dedicated customer support from our editorial team throughout your entire membership period.
Membership Renewal Guidelines
Maintain uninterrupted access to all exclusive member benefits, significant APC discounts, priority peer review processing, expedited editorial decisions, professional editing services, and comprehensive manuscript support services throughout your membership period for continuous publication support.
Advance MS Research Today
Join the distinguished global community of neurologists, neuroimmunologists, multiple sclerosis specialists, clinical researchers, rehabilitation medicine experts, and translational scientists advancing understanding of demyelinating diseases, autoimmune neuroinflammation, and therapeutic innovations worldwide. Start publishing your groundbreaking research with discounted APC rates, priority peer review, expedited editorial decisions, and worldwide visibility through our comprehensive open access publishing platform.